Summary
Twenty-four top-level body builders [13 anabolic steroid users (A); 11 non-users (N)] and 11 performance-matched controls (C) were examined to determine the effect on lipids, lipoproteins and apolipoproteins of many years of body building with and without simultaneous intake of anabolic steroids and testosterone. After an overnight fast, triglycerides (TG), total cholesterol (TOTC), high density lipoprotein cholesterol (HDLC), low density lipoprotein cholesterol (LDLC), the HDLC subfractions HDL2C and HDL3C, as well as apolipoprotein A-I (Apo A-I), apolipoprotein A-II (Apo A-II) and apolipoprotein B (Apo B) were determined. Both A and N, compared to C, showed significantly lower HDLC and higher LDLC concentrations, with the differences between A and C clearly pronounced. In a subgroup of 6 body builders taking anabolic steroids at the time of the study, HDLC, HDL2C, HDL3C, Apo A-I and Apo A-II were all significantly lower and LDLC was significantly higher than in a second subgroup of 7 body builders who had discontinued their intake of anabolic steroids at least 4 weeks prior to the study. In some single cases HDLC was barely detectable (2–7 mg·dl−1). The TG and TOTC remained unchanged. The present findings suggest that many years of body building among top-level athletes have no beneficial effect on lipoproteins and apolipoproteins. Simultaneous use of anabolic steroids results in part in extreme alterations in lipoproteins and apolipoproteins, representing an atherogenic profile. After discontinuing the use of anabolic steroids, the changes in lipid metabolism appear to be reversible.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alén M, Rahkila P (1984) Reduced high density lipoprotein cholesterol in power athletes: use of male sex hormone derivates, an atherogenic factor. Int J Sports Med 5:341–342
Alén M, Rahkila P, Marniemi J (1985) Serum lipids in power athletes self-administering testosterone and anabolic steroids. Int J Sports Med 6:139–144
Appelbaum-Bowden D (1984) Sex steroid effects on HDL2 and lipases. Clin Chem 30:1081
Berg A, Keul J, Ringwald B, Deus B, Wybitul K (1980a) Physical performance and serum cholesterol fractions in healthy young men. Clin Chim Acta 106:325–330
Berg A, Ringwald G, Keul J (1980b) Lipoprotein-cholesterol in welltrained athletes. A preliminary communication: reduced HDL-cholesterol in power athletes. Int J Sports Med 1:137–138
Castelli WP, Doyle JT, Gordon T, Hames C, Hulley SB, Kagan A, McGee D, Vicic WJ, Zukel WJ (1975) HDL cholesterol levels (HDLC) in coronary heart disease (CHD): a cooperative lipoprotein phenotyping study. Circulation 51 and 52 [Suppl II]:97
Clarkson PM, Hintermister R, Fillyaw M, Stylos L (1981) High density lipoprotein cholesterol in young adult weight lifters, runners, and untrained subjects. Hum Biol 53:251–257
Dufaux B, Assmann G, Hollmann W (1982) Plasma lipoproteins and physical activity: a review. Int J Sports Med 3:123–136
Durnin J, Rahaman M (1967) The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr 21:681–689
Goldberg L, Elliot DL, Schutz RW, Klosters FE (1984) Changes in lipid and lipoprotein levels after weight training. J Am Med Assoc 252:504–506
Haffner SM, Kushwaha RS, Foster DM, Applebaum-Bowden D, Hazzard WR (1983) Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism 32:413–420
Hazzard WR, Haffner SM, Kushwaha RS, Applebaum-Bowden D, Foster DM (1984) Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman. Metabolism 33:779–784
Hurley BF, Seals DR, Hagberg JM, Goldberg AC, Ostrove SM, Holloszy JO, Wiest WG, Goldberg AP (1984) High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use. J Am Med Assoc 252:507–513
Hurley BF, Hagberg JM, Goldberg AP, Seals DR, Ehsani AA, Brennan RE, Holloszy IO (1987) Resistive training can reduce coronary risk factors without altering 103-1 or percent body fat. Med Sci Sports Exerc 20:150–154
Johnson CC, Stone MH, Byrd RJ, Lopez-S M (1983) The response of serum lipids and plasma androgens to weight training exercise in sedentary males. J Sports Med 23:39–44
Kannel WB, Castelli WP, Gordon T (1979) Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study. Ann Intern Med 90:85–91
Kantor MA, Bianchini A, Bernier D, Sady SP, Thompson PD (1985) Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity. Med Sci Sports Exerc 17:462–465
Kindermann W, Keul J, Reindell H (1974) Grundlagen zur Bewertung leistungsphysiologischer Anpassungsvorgänge. Dtsch Med Wochenschr 99:1372–1379
Kokkinos PF, Hurley BF, Vaccaro P, Patterson JC, Gardner LB, Ostrove SM, Goldberg AP (1987) Effects of low- and high-repetition resistive training on lipoprotein-lipid profiles. Med Sci Sports Exerc 20:50–54
Kullmer T, Kindermann W (1985) Apolipoproteine and Lipoproteine bei unterschiedlicher körperlicher Aktivität und Leistungsfähigkeit. Klin Wochenschr 63:1102–1109
Lamb DR (1984) Anabolic steroids in athletics: how well do they work and how dangerous are they? Am J Sports Med 12:31–38
Lenders JWM, Demacker PNM, Vos JA, Jansen PLM, Hoitsma AJ, van't Laar A, Thien T (1988) Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders. Int J Sports Med 9:19–23
Lipid Research Clinics Program (1984) The lipid research clinics coronary primary prevention trial results. I. Reduction in incidence of coronary heart disease. J Am Med Assoc 251:351–364
Nikkilä EA, Taskinen MR, Rehunen S, Härkönen M (1978) Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins. Metabolism 27:1661–1671
Rost R, Hollmann W (1983) Athlete's heart — a review of its historical assessment and new aspects. Int J Sports Med 4:147–165
Schnabel A, Kindermann W (1982) Effect of maximal oxygen uptake and different forms of physical training on serum lipoproteins. Eur J Appl Physiol 48:263–277
Tran ZV, Weltman A, Glass GV, Mood DP (1983) The effects of exercise on blood lipids and lipoproteins: a metaanalysis of studies. Med Sci Sports Exerc 15:393–402
Webb OL, Laskarzewski PM, Glueck CJ (1984) Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism 33:971–975
Wieland H, Seidel D (1978) Fortschritte in der Analytik des Lipoproteinmusters. Inn Med 5:290–300
Wood PD, William L, Haskell WL, Blair SN, Williams PT, Krauss RM, Lindgren FT, Albers JJ, Ho PH, Farquhar JW (1983) Increased exercise level and plasma lipoprotein concentrations: a one-year, randomized, controlled study in sedentary, middle-aged men. Metabolism 32:31–39
Yki-Järvinen H, Koivisto VA, Taskinen MR, Nikkilä EA (1984) Glucose tolerance, plasma lipoproteins and tissue lipoprotein lipase activities in body builders. Eur J Appl Physiol 53:253–259
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fröhlich, J., Kullmer, T., Urhausen, A. et al. Lipid profile of body builders with and without self-administration of anabolic steroids. Europ. J. Appl. Physiol. 59, 98–103 (1989). https://doi.org/10.1007/BF02396586
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02396586